Home/Filings/4/0000920465-20-000018
4//SEC Filing

Wellinghoff Darryl 4

Accession 0000920465-20-000018

CIK 0000920465other

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 4:05 PM ET

Size

4.5 KB

Accession

0000920465-20-000018

Insider Transaction Report

Form 4
Period: 2020-01-14
Wellinghoff Darryl
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2020-01-14$8.23/sh+3,000$24,6776,545 total

Issuer

LA JOLLA PHARMACEUTICAL CO

CIK 0000920465

Entity typeother

Related Parties

1
  • filerCIK 0001770350

Filing Metadata

Form type
4
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:05 PM ET
Size
4.5 KB